Engine Biosciences (www.enginebio.com) is a venture-backed San Francisco- and Asia-based technology company pioneering network biomedicine. Our proprietary and patented technologies oriented around deciphering the complexity of biology networks include both high-throughput wet lab experimentation and artificial intelligence algorithms for drug discovery and cellular reprogramming. This platform, developed through several years of research by our scientific founding and leadership team who include faculty members at MIT, Harvard, Mayo Clinic, and UCSD, dramatically accelerates and reduces costs of the R&D process for new medical therapies. We are actively applying the platform internally and with partners across a range of disease indications.
Date | Amount | Type | Investors | Valuation |
---|---|---|---|---|
01/31/18 | $10,000,000 | Seed |
6 Dimensions Capital Baidu Ventures EDBI Nest.Bio Ventures Pavilion Capital WI Harper Group WuXi AppTec | undisclosed |